Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin

References

• Glenn GM, Kenney RT. Transcutaneous immunization. In: New Generation Vaccines. Levine MM, Kaper JB, Rappuoli R, Liu M, Good M (Eds.). Marcel Dekker, Inc., NY, USA (In Press).
   Google Scholar
• Jakob T, Udey MC. Epidermal Langerhans cells: from neurons to nature's adjuvants. Adv. Dermatol 14, 209–258 (1999).
   PubMedGoogle Scholar
• Yu RC, Abrams DC, Alaibac M, Chu AC. Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy. Br. J. Dermatol 131(6), 843–848 (1994).
   Google Scholar
• Udey MC. Cadherins and Langerhans cell immunobiology. Clin. Exp. Immunol 107(Suppl. 1), 6–8 (1997).
   Google Scholar
• Guereria-Burguerio F, Hall ER, Taylor DN et al Safety and immunogenicity of a prototype enterotoxigenic Escherichia cob vaccine administered transcutaneously. Infect. Immun. 70(4), 1874–1880 (2002).
   PubMed Web of Science ®Google Scholar
• Roberts MS, Walker M. Water the most natural penetration enhancer Marcel Dekker, NY, USA, 1–30 (1993).
   Google Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8 (4), 415–419 (2002).
   PubMed Web of Science ®Google Scholar
• Chen D, Erickson CA, Endres RL et al Adjuvantation of epidermal powder immunization. Vaccine 19(20-22), 2908–2917 (2001).
   PubMed Web of Science ®Google Scholar
• Baca-Estrada ME, Foldvari M, Ewen C, Badea I, Babiuk LA. Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine 18(17), 1847–1854 (2000).
   Google Scholar
• Glenn GM, Rao M, Matyas GR, Alving CR. Skin immunization made possible by cholera toxin. Nature 391(6670), 851 (1998).
   PubMed Web of Science ®Google Scholar
• Scharton-Kersten T, Yu J, Vassell R, O'Hagan D, Alving CR, Glenn GM. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits and unrelated adjuvants. Infect. Immun. 68(9), 5306–5313 (2000).
   Google Scholar
• O' Hagan DT (Ed.). Methods in Molecular Medicine. Humana Press, Inc., NJ, USA (2000).
   Google Scholar
• Dickinson BL, Clements JD. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63(5), 1617–1623 (1995).
   PubMed Web of Science ®Google Scholar
• Freytag LC, Clements JD. Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol Immunol 236,215–236 (1999).
   PubMed Web of Science ®Google Scholar
• Gluck R, Mischler R, Durrer P et al. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia cob heat-labile toxin as a mucosal adjuvant. J. Infect. Dis. 181(3), 1129–1132 (2000).
   Google Scholar
• Michetti P, Kreiss C, Kotloff KL et al Oral immunization with urease and Escherichia cob heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116(4), 804–812 (1999).
   PubMed Web of Science ®Google Scholar
• Snider DR The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Grit. Rev Immunol 15(3-4), 317–348 (1995).
   Google Scholar
• Weltzin R, Guy B, Thomas WD Jr, Giannasca PJ, Monath TR Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect. Immun. 68(5), 2775–2782 (2000).
   PubMed Web of Science ®Google Scholar
• Hammond SA, Walwender D, Alving CR, Glenn GM. Transcutaneous immunization: T-cell responses and boosting of existing immunity. Vaccine 19,2701–2707 (2001).
   PubMed Web of Science ®Google Scholar
• Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide- specific CTLs and protection against tumor development in vivo. J Immunol 158(2), 834–841 (1997).
   Google Scholar
• Neidleman JA, Ott G, O'Hagan D. Mutant heat-labile enterotoxins as adjuvants for CTL induction. In: Vaccine Adjuvants: Preparation Methods and Research Protocols. O'Hagan D (Ed.). Humana Press, NJ, USA, 327–336 (2000).
   Google Scholar
• Seo N, Tokura Y, Nishijima T, Hashizume H, Furukawa F, Takigawa M. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc. Natl Acad. Sci. USA 97(1), 371–376 (2000).
   Google Scholar
• Levine MM, Kaper JB, Black RE, Clements ML. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Nlicmbiol. Rev. 47(4), 510–550 (1983).
   Google Scholar
• Murphy GF, Messadi D, Fonferko E, Hancock WW. Phenotypic transformation of macrophages to Langerhans cells in the skin. Am. J Pathol 123(3), 401–406 (1986).
   PubMed Web of Science ®Google Scholar
• Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. 6(12), 1403–1406 (2000).
   PubMed Web of Science ®Google Scholar
• El-Ghorr AA, Williams RM, Heap C, Norval M. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice. FEMS Immunal Med. Microbial 29(4), 255–261 (2000).
   Google Scholar
• Gockel CM, Bao S, Beagley KW Transcutaneous immunization induces mucosal and systemic immunity: a potent 37(9), 537–544 (2000).
   Google Scholar
• Jakob T, Walker PS, Krieg AM, von Stebut E, Udey MC, Vogel JC. Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Thl responses. Int. Arch. Allergy Immunal 118 (2–4), 457–461 (1999).
   Google Scholar
• Kremer TB, Stevens SR, Gould JW, DiCarlo J, Quinby GE, Cooper KD. Intradermal granulocyte—macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans. Gun. Immunal 96(1), 29–37 (2000).
   Google Scholar
• Aiba S, Katz ST. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunal 145(9), 2791–2796 (1990).
   PubMed Web of Science ®Google Scholar
• Hernando RA, Ruby JC, Halliday GM. Changes in epidermal Langerhans cells, yö T-cells and CD4 T-cells after intradermal infection with recombinant vaccinia virus expressing cytokine genes. Immunal Cell Biol. 72(5), 383–389 (1994).
   Google Scholar
• Nagao S, Inaba S, Iijima S. Langerhans cells at the sites of vaccinia virus inoculation. Arch. Dermatol Res. 256(1), 23–31 (1976).
   Google Scholar
• Vassell R, Glenn GM, Udey MC, Scharton-Kersten T, Alving CR, Jakob T In: 5th National Symposium, Basic Aspects of Vaccines. MD, USA (1999).
   Google Scholar
• Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L,Glenn GM. Immunostimulant patch containing heat labile enterotoxin from E. coil enhances immune responses to injected influenza vaccine through activation of skin dendritic cells. JViral (In Press).
   Google Scholar
• Hammond SA, Guebre-Xabier M, Yu J, Glenn GM. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Grit. Rev Ther. Drug Carrier Sys. 18 (5), 503–526 (2001).
   Google Scholar
• Arrington J, Braun RP, Dong L etal. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. J Viral 76(9), 4536–4546 (2002).
   PubMed Web of Science ®Google Scholar
• Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunal 145 (9), 2833–2838 (1990).
   PubMed Web of Science ®Google Scholar
• Enioutina EY, Visic D, Daynes RA. The induction of systemic and mucosal immune responses to antigen—adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine 18(24), 2753–2767 (2000).
   PubMed Web of Science ®Google Scholar
• Gasparini R, Pozzi T, Montomoli E et al Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur. I Epidemial 17(2), 135–140 (2001).
   Google Scholar
• Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat. Biotechnol 17(11), 1075–1081 (1999).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C etal. Immunobiology of dendritic cells. Ann. Rev Immunal 18,767–811 (2000).
   PubMed Web of Science ®Google Scholar
• Morein B, Lovgren-Bengtsson K, Cox J. Modern adjuvants, functional aspects. In: Concepts in Vaccine Development. Kaufmann SHE (Ed.) Walter de Gruyter, Berlin, Germany, 243–263 (1996).
   Google Scholar
• Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388(6644), 782–787 (1997).
   PubMed Web of Science ®Google Scholar
• Rescigno M, Citterio S, Thery C etal. Bacteria-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells. Proc. Nall Acad. Sci. USA 95(9), 5229–5234 (1998).
   Google Scholar
• de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect. Dis. 179(1), 31–36 (1999).
   Google Scholar
• Hammond SA, Tsonis C, Sellins K et al Transcutaneous immunization of domestic animals: opportunities and challenges. Adv. Drug- Delivery Rev 43, 45–55 (2000).
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Vassell R, Matyas GR, Alving CR. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect. Immun. 67(3), 1100–1106 (1999).
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69(6), 3581–3590 (2001).
   PubMed Web of Science ®Google Scholar
• Watabe S, Xin K, Ihata A et al. Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19(31), 4434–4444 (2001).
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunal 161(7), 3211–3214 (1998).
   PubMed Web of Science ®Google Scholar
• Gebhart W, Metze D, Jurecka W IgA in human skin appendages. In: !!!!!!Immunodermatology. Caputo R (Ed.). CIC Edizioni Internazionali, Rome, Italy, 185 (1987).
   Google Scholar
• Okada T, Konishi H, Ito M, Nagura H, Asai J. Identification of secretory immunoglobulin A in human sweat and sweat glands. J Invest. Dermatol 90(5), 648–651 (1988).
   Google Scholar
• Hard GC. Electron microscopic examination of Corynebacterium ovis. Bacterial 97(3), 1480–1485 (1969).
   PubMed Web of Science ®Google Scholar
• Metze D, Kersten A, Jurecka W, Gebhart W Immunoglobulins coat microorganisms of skin surface: a comparative immunohistochemical and ultrastructural study of cutaneous and oral microbial symbionts. J Invest. Dermatol 96(4), 439–445 (1991).
   Web of Science ®Google Scholar
• Yu J, Cassels F, Scharton-Kersten T et al. Transcutaneous immunization using colonization factor and heat labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia cob. Infect. Immun. 70 (3), 1056–1068 (2002).
   PubMed Web of Science ®Google Scholar
• Wolf MK, de Haan LA, Cassels FJ et al The C56 colonization factor of human enterotoxigenic Escherichia coil contains two heterologous major subunits. PENIS Nlicrobiol. Lett. 148(1), 35–42 (1997).
   Google Scholar
• Levine MM, Ristaino P, Sack RB, Kaper JB, Orskov F, Orskov I. Colonization factor antigens I and II and Type 1 somatic pili in enterotoxigenic Escherichia colt relation to enterotoxin type. Infect. Immun. 39(2), 889–897 (1983).
   Google Scholar
• Wolf M, Hall E, Taylor D et al In: The 35th Joint Conference of the US—Japan Co-operative Medical Science Program. Baltimore, MD, USA (1999).
   Google Scholar
• Trach DD, Clemens JD, Ke NT etal. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349(9047), 231–235 (1997).
   PubMed Web of Science ®Google Scholar